The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, ...

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or overweight.

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

Learn what designers think is the most regrettable kitchen trend so you can avoid it in your own kitchen renovation.

IB+ Dashboard tracks companies, costs, profits, and surprising earning trends The dashboard report monitors 86 insurers, diverse business segments, EPS movements, expenses, and earning trends from ...

Discover how to transform everyday Dollar Tree finds into upscale, high-end DIY creations perfect for 2024 décor trends. This step-by-step tutorial shows you budget-friendly hacks and stylish ...

Marketed by Nothing as its first true flagship (though some beg to differ on this point), the Nothing Phone 3 garnered a lot of interest when it officially launched at the start of this month. Of ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.

In postmenopausal women with overweight or obesity receiving tirzepatide, use of MHT is associated with superior weight loss outcomes.